USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Suzhou RIBO LIFE Science Co., Ltd.

USPTO PatentsView assignee record - 16 granted patents across 10 technology areas, active 2016–2025. Filing-trend and competitive-moat analysis cross-referenced to USPTO Patent Public Search. Primary class: C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA).

16
Total patents granted
10
CPC technology areas
24.7
Avg claims per patent
+120%
5-year filing velocity

The verdict

Suzhou holds 16 US patents across 10 technology areas, rank #18,111 of 50,000 tracked assignees.

#18,111
of 50,000 US assignees by volume
Top 7%
by Innovation Score (55.8/100)
24.7
avg claims per patent
+120%
filing velocity, last 5 yrs

Portfolio overview

Suzhou RIBO LIFE Science Co., Ltd. has been granted 16 US utility patents between 2016 and 2025, placing Suzhou RIBO LIFE Science Co., Ltd. at rank #18,111 across all assignees tracked by PlainPatent. This portfolio spans 10 distinct Cooperative Patent Classification (CPC) subclasses, averaging 24.7 claims per patent with primary concentration in C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA). As a Foreign Corporation, Suzhou RIBO LIFE Science Co., Ltd. is one of the more focused assignees in the PatentsView dataset. The composite Innovation Score of 55.8/100 blends portfolio volume, filing velocity, technology breadth, and claim depth into a single comparable measure drawn directly from USPTO PatentsView records.

Filing cadence tells the strategic story. Between 2020 and 2025 the company received 11 grants, compared with 5 in the 2015–2019 window, a +120% shift in five-year velocity. An acceleration of this magnitude signals aggressive R&D investment and expanding technical ambition. The Foreign Corporation classification further shapes interpretation, since corporate, government, and individual filers pursue patents for materially different reasons.

Claim depth and technology breadth together indicate competitive posture. Suzhou RIBO LIFE Science Co., Ltd.'s 24.7 average claims per patent reflects complex, broadly scoped inventions that are difficult for competitors to design around, while concentration in 10 subclasses points to a focused technical program. Combined with portfolio volume, these signals let analysts, investors, and licensing professionals benchmark Suzhou RIBO LIFE Science Co., Ltd. against peers pursuing similar technology classes.

How does Suzhou compare?

Granted US patents 2015–2025 versus the largest corporate holders, this company marked ◀

patents

What this shows Suzhou holds 16 patents, placing it at rank #18,111 overall, well behind the volume leaders but ahead of the tens of thousands of smaller assignees in the dataset.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Suzhou's Innovation Score vs. every tracked assignee

Composite of portfolio volume, filing velocity, technology breadth, and claim depth (0–100)

56 Top 7% higher than 93% of 50,000 US assignees

0–10: 687 US assignees (1%). Below this entry. 10–20: 2,527 US assignees (5%). Below this entry. 20–30: 13,162 US assignees (26%). Below this entry. 30–40: 15,294 US assignees (31%). Below this entry. 40–50: 11,491 US assignees (23%). Below this entry. 50–60: 5,058 US assignees (10%). This entry sits in this band. 60–70: 1,537 US assignees (3%). Above this entry. 70–80: 234 US assignees (0%). Above this entry. 80–90: 10 US assignees (0%). Above this entry. 90–100: 0 US assignees (0%). Above this entry. This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2016–2025

012345 201620172022202320242025 2
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Suzhou RIBO LIFE Science Co., Ltd. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 1 6.3%
2017 4 25.0%
2022 3 18.8%
2023 2 12.5%
2024 4 25.0%
2025 2 12.5%

Patent Moat Analysis

Portfolio Volume Light
Tech Breadth Focused
Claim Depth Complex
Velocity Accelerating

Where it ranks

Overall rank by patents

#18,111

Across all tracked assignees

Innovation Score

55.8 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

Frequently Asked Questions

How many patents does Suzhou RIBO LIFE Science Co., Ltd. hold?
Suzhou RIBO LIFE Science Co., Ltd. holds 16 US granted patents filed between 2016 and 2025, spanning 10 technology areas.
What is Suzhou RIBO LIFE Science Co., Ltd.'s Innovation Score?
Suzhou RIBO LIFE Science Co., Ltd. has an Innovation Score of 55.8 out of 100. This composite metric weighs portfolio volume (40%), filing velocity (20%), technology breadth (25%), and claim depth (15%).
What technology areas does Suzhou RIBO LIFE Science Co., Ltd. focus on?
Suzhou RIBO LIFE Science Co., Ltd.'s top technology area is C12N (MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA) with 14 patents. The company has filed patents in 10 CPC subclasses total.
Is Suzhou RIBO LIFE Science Co., Ltd.'s patent filing rate increasing or decreasing?
Suzhou RIBO LIFE Science Co., Ltd.'s recent filing velocity is +120% compared to the prior five-year period. This indicates accelerating innovation.
What does claim depth mean for Suzhou RIBO LIFE Science Co., Ltd.'s patents?
Suzhou RIBO LIFE Science Co., Ltd.'s patents average 24.7 claims each. This indicates complex, broadly scoped patents that are harder for competitors to design around.
How is the Suzhou RIBO LIFE Science Co., Ltd. patent data sourced?
All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

Guides to patent portfolio analysis

How to use this portfolio

Suzhou's 16 grants land it in the top 7% by Innovation Score, but volume alone doesn't tell you where the strength sits.

  • Read that count against the largest US assignees before treating it as dominance - Suzhou ranks #18,111 of 50,000. Top 50 holders
  • Most of this portfolio concentrates in C12N - see who else leads that technology area. C12N leaders
  • Check what the four-part Innovation Score actually rewards before comparing it to another company. How the score works

Patent counts and the Innovation Score measure patenting activity, not commercial success or the legal strength of any patent. Many patents are filed defensively. Verify the status of an individual patent against official USPTO records.

Explore the patent dataset

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent Editorial

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Data sources used on this page
  • USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
  • Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
  • USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.